More on treatment de-escalation, biomarkers of response in human epidermal growth factor receptor 2 (HER2)-positive breast cancer: long-term outcomes and translational research findings of the PREDIX HER2 trial.

ABSTRACT:

SUBMITTER: Mano MS 

PROVIDER: S-EPMC10777231 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature